NASDAQ
Blueprint Medicines Corporation (BPMC) has a free cash flow growth of -85.87% as of Friday, May 29, 2026. This represents a 1549.09% decrease compared to its 12-month average of -5.21%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.